Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Steinberg

Showing results (1041-1050 of 1,520) with videos related to

Pageof 152
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanesNeelima Denduluri, Jennifer A Low, James J Lee, et al.
Blood|September 11, 2004
High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytologyUpendra Hegde, Armando Filie, Richard F Little, et al.
The American Journal of Cardiology|June 1, 2011
Coronary artery distensibility assessed by 3.0 Tesla coronary magnetic resonance imaging in subjects with and without coronary artery diseaseSebastian Kelle, Allison G Hays, Glenn A Hirsch, et al.
Ophthalmology|April 14, 1999
Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathyO Salomon, R Huna-Baron, S Kurtz, et al.
Gynecologic Oncology|August 1, 1996
A phase I/II study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy of poor-prognosis advanced-stage epithelial ovarian cancerE C Kohn, G A Sarosy, P Davis, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 7, 2009
Minimally invasive surgical ablation of atrial fibrillation: six-month resultsJames R Edgerton, James H McClelland, David Duke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinomaJ L Grem, N McAtee, R F Murphy, et al.
Cancer Research|July 21, 2018
Oncogenic BRAF<sup>V600E</sup> Governs Regulatory T-cell Recruitment during Melanoma TumorigenesisTamer B Shabaneh, Aleksey K Molodtsov, Shannon M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patientsB Fisher, A M Keenan, B S Garra, et al.
Science Translational Medicine|July 3, 2020
Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor modelsQun Jiang, Azam Ghafoor, Idrees Mian, et al.
Pageof 152

Showing results (1041-1050 of 1,520) with videos related to

Sort By:
Pageof 152
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanesNeelima Denduluri, Jennifer A Low, James J Lee, et al.
Blood|September 11, 2004
High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytologyUpendra Hegde, Armando Filie, Richard F Little, et al.
The American Journal of Cardiology|June 1, 2011
Coronary artery distensibility assessed by 3.0 Tesla coronary magnetic resonance imaging in subjects with and without coronary artery diseaseSebastian Kelle, Allison G Hays, Glenn A Hirsch, et al.
Ophthalmology|April 14, 1999
Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathyO Salomon, R Huna-Baron, S Kurtz, et al.
Gynecologic Oncology|August 1, 1996
A phase I/II study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy of poor-prognosis advanced-stage epithelial ovarian cancerE C Kohn, G A Sarosy, P Davis, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 7, 2009
Minimally invasive surgical ablation of atrial fibrillation: six-month resultsJames R Edgerton, James H McClelland, David Duke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinomaJ L Grem, N McAtee, R F Murphy, et al.
Cancer Research|July 21, 2018
Oncogenic BRAF<sup>V600E</sup> Governs Regulatory T-cell Recruitment during Melanoma TumorigenesisTamer B Shabaneh, Aleksey K Molodtsov, Shannon M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patientsB Fisher, A M Keenan, B S Garra, et al.
Science Translational Medicine|July 3, 2020
Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor modelsQun Jiang, Azam Ghafoor, Idrees Mian, et al.
Pageof 152